Journal
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
Volume 26, Issue -, Pages 74-79Publisher
GALENOS YAYINCILIK
DOI: 10.4274/2017.26.suppl.08
Keywords
Radioactive iodine; differentiated thyroid carcinoma
Ask authors/readers for more resources
Radioactive iodine therapy has evolved over the past 70 years from treatment of known metastatic thyroid carcinoma to include adjuvant use to decrease the incidence of recurrent disease and to ablation of normal remnant tissue following thyroidectomy, even for minimal tumor involvement. Advances in laboratory testing, development of drugs useful in radioiodine treatment, as well as advances in radiation detection and imaging instrumentation, have progressively improved the utility of radioiodine therapy of differentiated thyroid carcinoma. Guidelines have proliferated and they have become more detailed and complex. This trend is likely to continue as the science and technology involved increases in sophistication and efficacy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available